Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 2.33 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 2.07 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 475.00 Mn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 273.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 278.58 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 113.17 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 212.00 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 76.62 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 78.66 Mn |
| 10 | Nautilus Biotechnology | 143.03 Mn | 143.03 Mn | 175,000.00 | 6.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.33 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 7.16 Mn |
| Sep 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | 8.68 Mn |
| Dec 31, 2023 | 7.54 Mn |
| Sep 30, 2023 | 7.08 Mn |
| Jun 30, 2023 | 7.10 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 6.25 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | 6.36 Mn |
| Dec 31, 2021 | 6.92 Mn |
| Sep 30, 2021 | 6.32 Mn |